← Evidence map

ArticleAnnals of hematology2021

Nivolumab discontinuation and retreatment in patients with relapsed or refractory Hodgkin lymphoma.

Liudmila V Fedorova et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33528609